Buspirone Tablets

Buspirone Tablets

Form: Tablets

Strength: 5 mg, 7.5 mg, 10 mg, 15 mg, 30 mg

Reference Brands: Generics mainly and Buspar®(dis.cntd)

Category: Antipsychotropic Drugs

Buspirone tablets are FDA-approved in the United States for the management of generalized anxiety disorder (GAD) or the short-term relief of anxiety symptoms. As a non-scheduled medication, it offers a safer alternative to benzodiazepines with no risk of dependence. Manufacturing requires compliance with GMP standards, validated bioequivalence data for generics, and adherence to CNS safety labeling. In the European Union, buspirone is authorized via national procedures for similar indications. EU regulations require Risk Management Plans (RMPs) and post-marketing pharmacovigilance. To explore dossier-ready Buspirone tablets for global B2B sourcing, visit Pharmatradz.com.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details Get Enquiry
Zuclopenthixol tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.